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ABSTRACT
Background and Aims The prevalence of alcohol-related conditions is often reported as higher in hospital in-patients
compared with the general population. However, formal prevalence estimates are commonly derived from small studies
which report highly varied results. This systematic review and meta-analysis, within the UK hospital system, aimed to
estimate the pooled prevalence of the 26 ICD-10 conditions that are wholly attributable to alcohol in in-patient settings.
Methods We searched Medline, Embase, PsychINFO and CENTRAL from database inception until 1 May 2018. We in-
cluded studies of any design that reported the prevalence of one of 26wholly attributable alcohol conditions deﬁned by the
ICD-10. Studies were required to be conducted in one or more of the constituent nations of the United Kingdom and in an
in-patient setting (general wards, intensive care units, accident and emergency departments or mental health in-patient
units). Estimates were pooled using random-effects meta-analysis, and meta-regression tested study and patient factors
contributing to variation. Quality was assessed using the Grading of Recommendations Assessment Development and
Evaluation (GRADE) framework.Results A total of 124 studies were included, reportingon a total of 1 657614 patients.
The majority of studies reported on harmful use of alcohol and alcohol dependence, for which the pooled prevalence was
19.76% [95% conﬁdence interval (CI) = 15.61–24.26%] and 10.25% (95% CI = 7.06–13.96%), respectively. Mean pa-
tient age and type of in-patient settingwere identiﬁed as themain sources of variation in prevalence estimates, but not date
of data collection. Both estimates were deemed very low quality according to GRADE. Conclusions An estimated one in
ﬁve patients in the UK hospital system use alcohol harmfully, and one in 10 are alcohol-dependent.
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INTRODUCTION
The prevalence of alcohol-related conditions is often re-
ported as higher in hospital in-patients compared to
the general population [1]; however, formal prevalence
estimates are frequently derived from small studies which
report highly variable results. Such estimates are also often
restricted to subsets of patients with particular diseases [2],
making it difﬁcult to interpret the true overall prevalence of
these conditions in the in-patient population.
Alcohol-related conditions are estimated to cost the UK
National Health Service (NHS) approximately 3.5 billion
pounds per year [3]. In the current epoch of stretched
ﬁnancial resources, accurate quantiﬁcation of their preva-
lence in in-patient settings is important to ensure appropri-
ate resource allocation. Alcohol is a potential causative
factor for a plethora of conditions [4], and without
dedicated in-hospital screening many alcohol-related con-
ditions may be missed, and not receive appropriate treat-
ment [5]. Accurate prevalence estimates are therefore
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vital to inform patients, clinicians, commissioners and
policymakers as to the scale of the problem, and are cur-
rently particularly pertinent given the UK government’s
development of a new alcohol strategy and the NHS
10-year plan which includes funding allocations to combat
alcohol-related conditions [6].
The current evidence base is confused and contradic-
tory, with a large range of differing prevalence estimates of
alcohol-related conditions reported in the literature [7,8].
Previous attempts to synthesize data through systematic
review have made no attempt to pool data, have been nar-
ratively reported and have either focused on general medi-
cal in-patients or on subpopulations of patients with
particular conditions [9,10]. Reviews have also been nar-
rowly focused, often reporting on a singular alcohol-related
condition [11]. As such, no robust pooled estimates in the
UK hospital system are currently available in the literature.
The UKuses the International Classiﬁcation of Diseases
—Diagnostic Criteria for Research volume 10 (ICD-10
DCR) as the gold standard to code alcohol-related diagno-
ses [12]. This deﬁnes a diagnostic classiﬁcation system of
26 unique conditions which are wholly attributable to
alcohol. A list of these, along with their diagnostic codes,
is shown in Fig. 1.We aimed to use meta-analysis to gener-
ate pooled prevalence estimates of these 26 conditions
within the UK hospital in-patient system. Using meta-
regression, we aimed to test which study and patient
factors contribute to any observed variation in prevalence
estimates.
METHODS
This study is reported according to the Preferred Reporting
Items for Systematic Reviews and Meta-Analyses
(PRISMA) guidelines [13], and in line with the Meta-
analysis of Observational Studies in Epidemiology (MOOSE)
checklist [14]. The study did not require ethical approval.
Search strategy
We searched Medline, Embase, PsychINFO and the
Cochrane Central Register of Controlled Trials (CENTRAL)
from database inception to 1 May 2018. The complete
search strategies can be found in the Supporting informa-
tion, Fig. S1.
Study selection
Three authors (E.R., R.M. and S.E.) initially assessed titles
and abstracts and reviewed the full text of the remaining
articles for inclusion. Any discrepancy was resolved by dis-
cussion, and where agreement could not be reached a
fourth author (C.D.) was consulted. All relevant references
were checked for additional citations.
The review protocol can be found in the Supporting in-
formation, Fig. S2.We included studies of any design, using
any method of diagnostic ascertainment, that were
reported in English, and contained data which enabled
the calculation of a prevalence of any of the 26 wholly at-
tributable alcohol conditions as coded in ICD-10 [12]. In-
cluded studies had to be conducted in one or more of the
constituent nations of the United Kingdom (England, Scot-
land, Wales or Northern Ireland), and report a prevalence
in a hospital setting. The setting was deﬁned a priori into
four groups: general medical or surgical wards, intensive
care units (ICU), accident and emergency (A&E) or mental
health in-patient units.
We excluded studies conducted in speciﬁc substance
misuse in-patient settings such as detoxiﬁcation units or
rehabilitation centres. We also excluded studies which re-
ported only a prevalence of ‘alcohol use’ or a compound
prevalence such as ‘alcohol or drug dependence’. Studies
which reported only historical diagnoses or a ‘history of ’
a wholly attributable alcohol condition were also excluded.
Data extraction
Three authors (E.R., R.M. and S.E.) independently ex-
tracted data from all eligible studies using a standardized
data extraction spreadsheet and coding dictionary, which
can be found in the Supporting information, Figs S3 and
S4. In the case of incomplete reportingof data, we searched
studies’ online supplementary appendices, and contacted
authors as necessary.
The main outcome extracted was prevalence of a
wholly attributable alcohol condition. Other parameters
which were deemed a priori to have the potential to con-
tribute to variation in prevalence estimates were also
extracted. These included: type of patient population,
setting, type of diagnostic assessment and whether this
was considered robust, mean age of sample, number of
females, year of data collection and the constituent nation
of the United Kingdom in which the study was conducted.
A complete list with descriptions can be found in the
Supporting information, Fig. S5.
Some studies reported prevalence estimates in more
than one sample of patients, or for more than one wholly
attributable alcohol condition; these estimates were ex-
tracted separately. Where multiple studies reported on the
same patient sample the more conservative estimate was
used for meta-analysis.
Quality assessment
The quality of each pooled prevalence estimate was
assessed using the Grading of Recommendations Assess-
ment, Development and Evaluation (GRADE) framework.
Each estimate is given a rating of ‘high’, ‘moderate’, ‘low’
or ‘very low’ quality based upon scores in ﬁve domains: risk
of bias, inconsistency, indirectness, imprecision and other
considerations. Due to the observational nature of the data
the default quality score is ‘low’, which can then be up- or
downgraded according to the quality of the evidence for
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Figure 1 The 26 wholly attributable alcohol
diagnoses as coded in the International
Classiﬁcation of Diseases Diagnostic Criteria for
Research Volume 10 (ICD-10 DCR) [12]
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each estimate. Risk of bias was assessed using a quality as-
sessment tool adapted from the Newcastle–Ottawa Scale
[15] (see Supporting information, Fig. S6). Three reviewers
(E.R., R.M. and S.E.) independently scored the quality of
each study. Any discrepancy was resolved by discussion,
and where agreement could not be reached a fourth au-
thor (C.D.) was consulted. A complete description of the
GRADE quality scoring can be found in the Supporting in-
formation, Fig. S7.
Statistical analysis
Individual prevalence estimates for each of the 26 condi-
tions were stratiﬁed into four types of patient population:
(1) non-selective patients, i.e. patients without any pre-
speciﬁed characteristics who were sampled solely due to
being in an in-patient setting, (2) patients with speciﬁc
alcohol diagnoses, (3) patients with speciﬁc health disor-
ders and (4) patients within speciﬁc medical specialities.
Within these groups, prevalence estimates were pooled in
meta-analysis if there were ≥ 2 estimates of the same con-
dition in the same patient population grouping. All esti-
mates from the non-selective patient population were
pooled, and estimates from patients with the same alcohol
speciﬁc diagnosis, the same health disorder or from the
samemedical specialitywere also pooled.Where only a sin-
gle prevalence estimate was available within a particular
patient population this was reported individually.
True prevalence was likely to vary between studies due
to a variety of factors, including differences in study design
and diagnostic deﬁnitions. As such, a high degree of het-
erogeneity was anticipated and we chose a priori to per-
form random-effects meta-analysis [16]. Prevalence as a
measure is bounded by 0 and 100%, and some reported
prevalence estimates may be close to these boundaries.
As a normal approximation can break down at these ex-
tremes we used the Freeman–Tukey double arcsine trans-
formation as a method of stabilizing the variances [17].
Heterogeneity was examined through meta-regression
if there were sufﬁcient numbers of prevalence estimates
(n ≥ 10) [18]. Parameters were sequentially entered as uni-
variate explanatory variables to assess their contribution to
the variation in the prevalence estimates. Meta-regression
was restricted a priori to estimates derived from samples
in which the mean age of patients was ≥ 18 years of age,
as this is the legal limit to purchase alcohol in the United
Kingdom, and it was felt to include studies in which pa-
tients had a mean age < 18 would not lead to results that
were clinically meaningful.
We compared τ2 (the between-study variance) and I2
values from the meta-analysis with the τ2 and I2 values,
and the adjusted R2 (the percentage of variation in the
prevalence estimates explained by parameter) from each
univariate meta-regression. Where explanatory variables
were continuous or binary, results were reported to
show how the pooled prevalence estimate changes with
each unit increase of the explanatory variable. For categor-
ical variables, results were reported to show how pooled
prevalence estimates differ across categories. If there was
a reduction in the τ2 and I2, and an R2> 0 for any individ-
ual explanatory variable on univariatemeta-regression, we
planned to introduce these variables using a forward
approach into a multivariate meta-regression model,
provided that this would not breach the rules of data
sparsity and result in overparameterization (in this case
deﬁned as fewer than 10 prevalence estimates for each co-
variate) of the model. All analyses were conducted in Stata
IC version 15.
RESULTS
The search generated 1524 unique results and 41 addi-
tional references were identiﬁed from citation searching,
leading to a total of 1565. We examined 357 full texts
and included 124 studies. Two hundred and thirty-three
studies were excluded; common reasons for exclusion in-
cluded reporting in a non-in-patient sample (n = 43) and
reporting the prevalence of ‘alcohol use’ or alcohol ‘prob-
lems’ (n = 72). Full reasons for each study’s exclusion
can be found in the Supporting information, Table S1.
The 124 included studies consisted of 127 unique
patient samples, and reported 171 individual prevalence
estimates in a total of 1657614 patients. The PRISMA di-
agram in Fig. 2 describes the study selection. Two studies
were RCTs, 14 were cohort studies and 188 were cross-
sectional.
A description of all included study characteristics can
be found in the Supporting information, Table S2. No stud-
ies reported a prevalence of alcohol-induced residual and
late-onset psychotic disorder (F10.7), accidental poisoning
by and exposure to alcohol (X45), alcoholic fatty liver
(K70.0), alcohol-induced pseudo-Cushing’s syndrome
(E24.4), degeneration of the nervous system due to alcohol
(G31.2), alcoholic cardiomyopathy (I42.6) or fetal alcohol
syndrome (Q86.0); 64 of 124 of the included studies
offered no description as to how their reported wholly
attributable alcohol condition was diagnosed. Of the 60
that did report a description, 51 were considered to have
used robust diagnostic methods to ascertain the diagnosis.
Non-selective patients
Eighty-three prevalence estimates were available in non-
selective patients. Pooled prevalence estimates and their
GRADE quality rating stratiﬁed by setting can be found in
Table 1.
Twenty-nine prevalence estimates were available for a
diagnosis of harmful use of alcohol F10.1, 27 of which
were considered to have used a robust diagnostic assess-
ment; the overall pooled prevalence using all estimates
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was 19.76% [95% conﬁdence interval (CI) = 15.61–
24.26%]. Twenty-three prevalence estimates were avail-
able for a diagnosis of alcohol dependence F10.2, 18 of
which were considered to have used a robust diagnostic as-
sessment; the overall pooled prevalence using all estimates
was 10.25% (95% CI = 7.06–13.96%). Both estimates
were deemed ‘very low’ quality according to GRADE. For-
est plots for these analyses can be found in Figs 3 and 4.
Forest plots for prevalence estimates for all other wholly
attributable alcohol conditions and GRADE evidence pro-
ﬁles in non-selective patients can be found the Supporting
information, Fig. S8 and Table S3.
Patients with a speciﬁc alcohol diagnosis, speciﬁc
health disorders and within a speciﬁc medical speciality:
Three prevalence estimates were available in patients
with a speciﬁc alcohol diagnosis, and no prevalence esti-
mates could be combined in meta-analysis.
Seventy-ﬁve prevalence estimates were available in
patients with speciﬁc health disorders, and meta-analysis
was possible for eight wholly speciﬁc alcohol diagnoses.
Four estimates reported a prevalence of harmful use
of alcohol in patients with self-harm (16.14%, 95%
CI = 3.07–36.54%), two estimates reported a prevalence
of harmful use of alcohol in patients with self-poisoning
(2.50%, 95% CI = 1.01–4.54%), two estimates reported
a prevalence of alcohol dependence in patients with serious
mental illness (16.76%, 95% CI = 13.10–20.76%), three
estimates reported a prevalence of alcohol dependence
in patients with self-harm (11.17% 95% CI = 8.35–
14.32%), two estimates reported a prevalence of alcoholic
hepatitis in patients with decompensated cirrhosis (9.93%,
95% CI = 7.67–12.44%), ﬁve estimates reported a preva-
lence of alcoholic cirrhosis in patients with decompensated
cirrhosis (74.39%, 95% CI = 52.82–91.16%), three esti-
mates reported a prevalence of alcoholic liver disease, un-
speciﬁed in patients with chronic liver disease (52.70%,
95% CI = 29.55–75.25%) and seven estimates of alco-
hol-induced acute pancreatitis in patients with
Figure 2 Preferred Reporting Items for Systematic Reviews andMeta-Analyses (PRISMA) ﬂow diagram describing study selection [Colour ﬁgure can
be viewed at wileyonlinelibrary.com]
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acute pancreatitis (23.55%, 95% CI = 17.39–30.32%). All
were deemed to be ‘very low’ quality according to GRADE.
Eleven prevalence estimates were available in patients
within a speciﬁc medical speciality, and meta-analysis
was possible for two estimates which reported harmful
use of alcohol in patients in high-security hospitals
(7.19% 95% CI = 6.03–8.43%). This was deemed to be
‘very low’ quality according to GRADE.
All prevalence estimates, their GRADE evidence proﬁles
and forest plots can be found in the Supporting informa-
tion, Tables S4–S9 and Figs S9–S10.
Meta-regression
Two pooled prevalence estimates contained data from ≥ 10
studies: harmful use of alcohol and of alcohol dependence
in non-selective patients. Tables 2 and 3 show the complete
results of the meta-regression.
When restricted to samples where the mean age of pa-
tients was > 18 years, univariate meta-regression data
from 13 prevalence estimates showed that the mean age
of patients explained 84.07% of the variation in the preva-
lence of harmful use, and data from seven prevalence
estimates showed that the mean age of patients explained
100% of the variation in prevalence of alcohol dependence.
Due to the low number of data points used to estimate
these parameters, they should be interpreted with caution.
Therewas strong evidence that for every 1-year increase in
the mean age of patients the prevalence of harmful use of
alcohol reduces by 0.81% (95% CI = –1.19 to 0.44%,
P = 0.001), and strong evidence that for every 1-year in-
crease in the mean age of patients the prevalence of
alcohol dependence reduces by 0.80% (95% CI = –1.36
to 0.24%, P < 0.001). Bubble plots displaying the
relationship between change in mean age and change in
prevalence estimates can be found in the Supporting
Figure 3 Forest plot of the pooled prevalence for harmful use of alcohol in non-selective in-patients in the UK hospital system stratiﬁed by setting
and ordered by the year in which the study was conducted [Colour ﬁgure can be viewed at wileyonlinelibrary.com]
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information, Fig. S11. The alcohol dependence model
contained data from only seven prevalence estimates and
suffers from overparameterization; accordingly, this result
should be interpreted with caution.
Univariate meta-regression data from 28 prevalence
estimates showed that type of setting explained 79.26%
of the variation in the prevalence of harmful use, and data
from 23 prevalence estimates showed that type of setting
explained 60.84% of the variation in the prevalence of
alcohol dependence. Individual prevalence estimates for
each different type of setting can be found in the forest plots
in Figs 3 and 4. However, as setting is a categorical variable
with four groups, both models for harmful use of alcohol
and alcohol dependence suffer from overparameterization,
and these results should be interpreted with caution.
It is notable that neither the year of data collection,
whether the study reported a robust diagnostic assessment
nor the constituent nation of the United Kingdom inwhich
the study was conducted appeared to substantially explain
or contribute to the variation in prevalence estimates on
meta-regression.
Due to data sparsity, we were unable to combine
any covariates in multivariate meta-regression. As there
were ≥ 10 studies included for these pooled prevalence
estimates funnel plots were generated and can be seen in
the Supporting information, Fig. S12.
DISCUSSION
Approximately one in ﬁve in-patients in hospital in the
United Kingdom is using alcohol harmfully, and one in
10 is alcohol-dependent. Compared to the UK general pop-
ulation this is 10 and eight times higher, respectively [19].
High levels of heterogeneity were observed, even within
similar patient populations, and the data suggest that the
main sources of variation are (a) different types of in-
patient setting and (b) the mean age of patients.
Figure 4 Forest plot of the pooled prevalence for alcohol dependence in non-selective in-patients in the UK hospital system stratiﬁed by setting and
ordered by the year in which the study was conducted [Colour ﬁgure can be viewed at wileyonlinelibrary.com]
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Harmful use ranges from being most prevalent in men-
tal health in-patient units to least prevalent in general
wards. Alcohol dependence ranges from being most preva-
lent in A&E to least prevalent in general wards. We might
have anticipated the prevalence to be higher in mental
health in-patient units and A&E due to the high level of
substance use comorbidity in patients with psychiatric ill-
ness and those with injuries [20,21]. This appears to be
Table 3 Univariate meta-regression of study and patient characteristics on prevalence of alcohol dependence in non-selective patients in
the UK hospital system.
Alcohol dependence in non-selective
patients
Prevalence
estimates (n)
Patients
(n) Prevalence LCI UCI τ2 I2 (%)
23 992 784 10.25 7.06 13.96 0.070 99.75
Prevalence
estimates (n)
Patients
(n) Beta LCI UCI τ2 I2 (%) P-valuea
Adjusted
R2 (%)
Is the study a conference abstract?
(binary)
23 992 784 1.39 11.80 9.03 0.004 96.21 0.79 0
Is the alcohol diagnosis diagnostic
assessment robust? (binary)
23 993 784 1.09 9.30 7.13 0.004 95.22 0.79 0
Mean age of patients (continuous) 7 7496 0.80 1.36 0.24 0.000 0.00 0.02 100.00
Proportion female (continuous) 10 8588 0.03 0.29 3.50 0.002 46.80 0.83 0
Total Newcastle–Ottawa scale
quality score (continuous)
23 992 784 0.31 2.14 2.77 0.004 95.00 0.79 0
Year study conducted in
(continuous)
16 986 504 0.45 1.10 2.01 0.004 94.59 0.54 0
Type of setting patients admitted
to (categorical)
23 992 784 – – – 0.001 64.09 0.009 60.84
Nation study conducted in
(categorical)
23 992 784 – – – 0.004 95.38 0.40 2.01
aResult from t-test where the null hypothesis was no linear relationship between prevalence and each explanatory variable. LCI = lower conﬁdence interval;
UCI = upper conﬁdence interval; τ
2
= between-study variance; adjusted R
2
= percentage of variation in prevalence explained by a particular covariate
Table 2 Univariate meta-regression of study and patient characteristics on prevalence of harmful use of alcohol in non-selective patients
in the UK hospital system.
Harmful use of alcohol in non-
selective patients
Prevalence
estimates (n)
Patients
(n) Prevalence LCI UCI τ2 I2 (%)
28 23529 20.47 17.39 23.73 0.04 96.99
Prevalence
estimates (n)
Patients
(n) Beta LCI UCI τ2 I2 (%) P-valuea
Adjusted
R2 (%)
Is the study a conference abstract?
(binary)
28 23529 3.60 16.82 9.62 0.008 82.64 0.58 0
Is the alcohol diagnosis diagnostic
assessment robust? (binary)
28 23529 10.38 23.89 3.14 0.006 76.83 0.13 14.20
Mean age of patients (continuous) 13 5838 0.81 1.19 0.44 0.001 42.49 0.001 84.07
Proportion female (continuous) 18 10925 0.16 0.44 0.12 0.011 84.18 0.25 2.51
Total Newcastle–Ottawa scale
quality score (continuous)
28 23529 0.02 3.78 3.75 0.008 82.63 0.99 0
Year study conducted (continuous) 19 17360 0.35 1.94 2.64 0.006 77.99 0.75 0
Type of setting patients admitted to
(categorical)
28 23529 – – – 0.002 52.59 < 0.001 79.26
Nation study conducted in
(categorical)
28 23529 – – – 0.008 80.58 0.46 0
aResult from t-test where the null hypothesis was no linear relationship between prevalence and each explanatory variable. LCI = lower conﬁdence interval;
UCI = upper conﬁdence interval; τ
2
= between-study variance; adjusted R
2
= percentage of variation in prevalence explained by a particular covariate.
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supported by the data which, despite high I2 values, dem-
onstrate coherent patterns of prevalence estimates across
each setting. It seems reasonable to conclude that setting
plays an important role in the variation of the prevalence
in hospital settings.
Mean patient age demonstrates strong evidence of
a linear association with prevalence of both harmful
use and alcohol dependence, after restriction to those
samples with a mean age > 18 years. This ﬁts with what
we may have expected a priori; however, the strength of
association is marked and the mean age of patients may
perhaps be more important in determining the overall
in-hospital prevalence than is currently considered in clin-
ical practice.
Little of the variation appears to be explained by year
of data collection. Diagnostic criteria and case deﬁnitions
for wholly attributable alcohol diagnoses have changed
substantially during the time-period covered in the re-
view. Classiﬁcation has changed with each iteration of
the ICD [12], alongside societal and regulatory changes
in what is considered a high-risk level of drinking.
Changes over time in coding practice may also have af-
fected the accuracy of prevalence estimates. Throughout
the United Kingdom, in-hospital diagnoses are coded ac-
cording to the ICD-10 in a system known as ‘Hospital Ep-
isode Statistics’ (HES) [22]. During the time–course
studied in this review, sequentially more diagnoses have
been recorded for each patient per in-patient episode
(e.g. in 2000 the number of coded diagnoses increased
from seven to 14, and in 2007 it increased again to
20). This has the potential over time to have
underestimated prevalence due to the previous lack of
space for alcohol attributable conditions to be recorded.
However, when investigated through meta-regression,
the year of data collection did not appear to contribute
substantially to the variation in prevalence estimates,
nor was there a coherent pattern of the effect of time
on visual inspection of the data.
It is also notable that little of the variation appears to
be explained by gender, as in the United Kingdom general
population estimates would suggest that higher numbers
of males meet the criteria for harmful use [19]. This may
potentially be explained by fewer males, or greater num-
bers of females seeking in-patient health care.
The study has several strengths and limitations. We
implemented robust methods to conduct the review, using
a broad search strategy, and a pre-deﬁned protocol to cap-
ture studies of any design. However, prevalence estimates
are not often the primary aim of a study, and as such were
often buried within the main body of article texts, preva-
lence not speciﬁcally indexed as an outcome. This may
have led to some studies being missed at the inclusion
stage. We chose to limit included studies to those only re-
ported in the English language; however, as this review
was focused on the United Kingdom itwas deemed unlikely
that studies would be reported in languages other than
English.
A further caveat is that formal evaluation of the quality
of all prevalence estimates was either ‘low’ or ‘very low’ ac-
cording to GRADE, resulting in little variation in estimates
being explained by study quality. GRADE was, however,
initially designed to focus on intervention studies; as its
use has becomemore widespread there have been critiques
regarding its application to observational data. A 2013
survey of public health researchers identiﬁed GRADE’s
limited applicability to diverse epidemiological study types
as a key drawback [23]. It should be noted that the GRADE
default position to begin the overall quality rating at ‘low’
for observational data seemingly does not take into ac-
count that observational studies are the most appropriate
study design to obtain prevalence estimates. Another
drawback is that the criteria requiring fulﬁlment in order
to upgrade the quality rating do not translate easily when
the outcome measure is a prevalence estimate. These
criteria include a ‘largemagnitude of effect’, demonstration
of a ‘dose–response gradient’ or consideration of adequate
control of confounding [24]. Nevertheless, while we could
have chosen to simply use the total Newcastle–Ottawa
scale score as a quality measure, as has been performed
in other systematic reviews of prevalence data [25],
GRADE provides a single overall quality rating per esti-
mate, having taken into account additional potential
sources of bias including inconsistency and publication
bias, which are important in prevalence meta-analyses
[18]. As such, GRADE was deemed the most appropriate
method to assess quality measures despite the limitations
outlined above.
More than half the studies did not report their method
of diagnostic ascertainment, and those that did used differ-
ent methods or screening instruments. Even those studies
using the same screening instrument, e.g. the Alcohol
Use Disorders Identiﬁcation Test (AUDIT), often either a
different cut-off was used to diagnose certain disorders
(e.g. AUDIT ≥ 15, ≥ 16 or ≥ 20 for alcohol dependence)
[26] or ranges were not speciﬁed for cut-offs, leading to
the potential for more severe alcohol disease such as
dependence being misclassiﬁed as harmful use of alcohol
[27]. This may have the consequence of overestimating
the prevalence of those less severe conditions, while
underestimating the prevalence of more severe conditions.
As such, the ﬁnding that whether or not the study reported
a robust diagnostic assessment appeared to substantially
explain or contribute to the variation in prevalence esti-
mates should be interpreted with caution, given the differ-
ent diagnostic ascertainment methods used. With regard
to the assessment of harmful use and alcohol dependence
in non-selective patients, more than 75% of both diagnoses
were considered to be robust. Meta-regression also
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demonstrated that whether the study reported a robust di-
agnostic assessment for the wholly attributable alcohol
condition did not appear to contribute substantially to
the variation in prevalence estimates.
While alcohol is wholly causative for the conditions
discussed in this review, we acknowledge that it is also a
contributory factor to a plethora of other conditions. As
such, this study does not purport to be an exhaustive explo-
ration of the burden of disease attributable to alcohol in the
UK hospital system.
In 1982 McIntosh stated that it was ‘not possible to
say, either precisely or even within what limits, what pro-
portion of general hospital patients have alcohol-related
disorders’ [1]. We hope this review goes some way to
demonstrate this proportion within the in-patient popula-
tion. While clinicians may be aware that the prevalence
of these conditions is ‘high’ in hospital settings, prevalence
is often discussed in the literature without quantiﬁcation
[4]. We have attempted to provide this quantiﬁcation,
and are of the opinion that our results represent a much
larger magnitude than is currently anecdotally assumed.
Our data support the fact that hospital clinicians
should be skilled in the diagnosis and management of
alcohol-related conditions given their ubiquity in this
setting. Nevertheless, current rates of formal screening
for alcohol-related conditions in hospital remain low
[5]. Given the fact that other chronic diseases with a
lower in-hospital prevalence (e.g. diabetes) are both rou-
tinely screened for and often have dedicated in-hospital
specialist care teams, our study provides weight to advo-
cate for increased routine universal screening and,
given the fact that hospital clinicians often report
that they do not feel conﬁdent in the management of
alcohol use disorders [28], our study adds to the evidence
to support improved training concerning alcohol-related
conditions. Due consideration should be given to the
need for dedicated in-patient specialist alcohol care
teams to ensure that the widespread problem is being ad-
dressed, particularly in the current context of diminishing
numbers of specialist alcohol services in the United
Kingdom.
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